openPR Logo
Press release

Clinical Radiation Oncology Training at Mannheim Medical Centre, Germany

06-20-2011 09:15 AM CET | Health & Medicine

Press release from: Dharamshila Hospital and Research Centre

Cancer Hospital India

Cancer Hospital India

New Delhi, June 17, 2011 : Dharamshila Hospital And Research Centre has recently acquired a new Elekta Synergy Linear Accelerator capable of IMRT, IGRT, SRS, SRT and SBRT. The clinical and technical application training of this machine is usually scheduled at a teaching Hospital in Germany. Dr. Hari Mohan, Consultant – Radiation Oncology, Dharamshila Hospital visited Mannheim Medical Centre, Germany for clinical training on Elekta Synergy.

Mannheim Medical Centre, Germany is affiliated to University of Heidelberg, Germany, the oldest university of Germany. The department of Radiation Oncology at this hospital is equipped with CT simulator, 3 Linear Accelerators, intraoperative Brachytherapy for breast, head and neck and pelvic tumors and interstitial Brachytherapy with iodine seeds for prostate cancer.

He has received a first hand experience of treatment planning with VMAT on Monaco planning system. It was enlightening to know the protocols and planning methodology being used at this centre. All the patients undergo CT simulation as a routine and are planned for radiotherapy with utmost care and compassion. Respiratory gating is used for tumors of lung, breast and chest wall.

The treatment is planned with Oncentra Masterplan, for 3D-conformal radiotherapy and with 5 different inverse treatment planning systems (Corvus, Oncentra Masterplan and preciseplan exclusively for static IMRT, Ergo+++ for VMAT treatments and Monaco for both static and VMAT treatments).

He saw IGRT being performed with stereotactic ultrasound and with X-ray volume imaging (Cone Beam CT, Elekta XVI on Elekta synergy).

Treatments were recorded with the MOSAIQ Electronic Medical Record (EMR) of the patient. MOSAIQ oncology PACS archives all critical data.
IMRT was used for the treatment of almost all patients of Head and neck, prostate and stomach. Tumor relapses near the spine were also treated with IMRT. IGRT protocols are strictly followed for all IMRT patients.

He got experience in Extracranial frameless SRT with image guidance (IGRT). In addition, LDR brachytherapy for prostate cancer is also available.

The department actively collaborates with other departments within the framework of Comprehensive Cancer Centre. This was very similar to the tumor board meeting which we routinely conduct at our hospital wherein every new cancer patient’s management plan collaboratively is arrived at after a joint meeting with Radiation, Medical and surgical oncologists together with oncopathologist and imaging oncology experts.

We at Dharamshila Hospital, have the same setup for Radiotherapy treatment and planning. In addition, we also have Nucletron HDR Brachytherapy facilities which are not there at Mannheim Medical Centre. It is indeed a pleasure to realize that we have the same world class technology which is available at most of the top institutes all over the world. We have been treating our patients with IMRT for the last 6 years and IGRT with VMAT is also now fully functional. That brings us at par with some of the best Radiotherapy departments across the globe. And we sincerely hope that the treatment outcome of our cancer patients will now also be at par with the best internationally accepted standards.

A group of concerned relatives and friends of cancer patients felt the need to provide complete cancer treatment under one roof. They felt it was their Dharma (duty) to provide to cancer patients what was not available to their near and dear ones when they suffered with cancer.

Dharamshila Hospital and Research Centre
Dharamshila Marg, Vasundhara Enclave
Delhi - 110096, INDIA
Email- contact@dhrc.in
Website - http://www.dhrc.in

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Radiation Oncology Training at Mannheim Medical Centre, Germany here

News-ID: 179890 • Views:

More Releases from Dharamshila Hospital and Research Centre

Haplo-Identical Bone Marrow Transplantation, “The Glass is Always Half Full”
Haplo-Identical Bone Marrow Transplantation, “The Glass is Always Half Full”
A 25 year old IT professional was struck with Hodgkin ’s disease which is one of the most curable cancers. He was treated with standard chemotherapy and the disease went away only to reappear a few months later. This time he received local radiation and Autologous Bone Marrow Transplantation (BMT). However, the response was shortlived and the cancer sprung its ugly head within 6 months. The young man and his distraught
Most Promising Healthcare Chain 2014 for Dharamshila Hospital & Research Centre
Most Promising Healthcare Chain 2014 for Dharamshila Hospital & Research Centre
Eminent Healthcare Expert Dr Sandeep Chatrath receives the prestigious India’s Most Promising Healthcare Chain 2014 for Dharamshila Hospital & Research Centre ILc Power Brand 2014. Dr Sandeep Chatrath also declared by the Jury as the CEO of the Year Healthcare 2014 at Asia’s Biggest Leadership Event, the 5th Annual India Leadership Conclave 2014 The prestigious & coveted Awards were presented in a glittering award ceremony

More Releases for IMRT

Radiotherapy Market | Ongoing Trends and Recent Developments | Major Key Players …
Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of this market. Additionally, the growing adoption of radiotherapy procedures for cancer treatment, increasing use of particle therapy for cancer treatment, and the rising number of conferences and symposia focusing on the advancements in radiotherapy are some of the other major factors driving the growth of this market. What the market looks like? According to
Radiotherapy Market worth $6.8 billion by 2023 | Varian Medical Systems, Inc. (U …
The report "Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT, Stereotactic), Brachytherapy (LDR, HDR)), Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Application (Prostate, Breast), End User (Hospital) - Forecasts to 2023", The global radiotherapy market is projected to reach USD 6.8 billion by 2023 from USD 5.6 billion in 2018, at a CAGR of 4.1% Browse 150 market data Tables and 46 Figures spread through 226 Pages and in-depth
Radiotherapy Market 2024: Analysis By Types, Industry Top Players, Regions & Mar …
Global Radiotherapy Market is expected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024. New report title “Global Radiotherapy Market, By Type (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast
Asia Pacific (APAC) Radiotherapy Market Analysis 2017-2024: Varian Medical Syste …
APAC Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Country (China, India, Japan, South Korea, Singapore, Australia, Rest of APAC) and Forecast to 2024 APAC Radiotherapy Market has accounted for USD 1.1 billion in 2016, and is expected to
Global External Beam Radiotherapy Market Insights by Size, Status and Forecast 2 …
HTF MI recently broadcasted a new study in its database that highlights the in-depth market analysis with future prospects of External Beam Radiotherapy market. The study covers significant data which makes the research document a handy resource for managers, industry executives and other key people get ready-to-access and self analyzed study along with graphs and tables to help understand market trends, drivers and market challenges. Some of the key
Global Radiotherapy Market By Type (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomothe …
Global Radiotherapy Market is expected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Global Radiotherapy Market, By Type (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic),